Literature DB >> 24664669

Autism and anxiety in males with fragile X syndrome: an exploratory analysis of neurobehavioral profiles from a parent survey.

Victor B Talisa1, Lia Boyle, Daina Crafa, Walter E Kaufmann.   

Abstract

Although it is suspected that anxiety modifies the clinical presentation of autism in fragile X syndrome (FXS), neuropsychiatric co-morbidity profiles of these two disorders have not been extensively studied. The National Fragile X Survey was completed for 1,027 males with FXS, for whom yes/no information regarding the presence of several disorders is provided. Although the survey exhibited limited depth and lacked validation by standardized measures, this exploratory study was conducted to take advantage of the data as an opportunity for identifying future lines of inquiry. We addressed the following questions: (i) how do the co-morbidity profiles of FXS males with both autism and anxiety compare to those without anxiety?; (ii) do individuals with autism exhibit specific co-morbidity profiles compared to FXS males with anxiety only, or without either autism or anxiety?; (iii) how do co-morbidity profiles in children ages 3-11 differ from profiles of individuals >12 years? The group with autism and anxiety reported the highest prevalence of attention problems, hyperactivity/impulsivity, self-injurious behavior and aggressiveness. In addition, the lowest prevalence rates of these conditions were often observed in non-anxious groups regardless of autism status. Overall, this exploratory analysis generated several hypotheses for further study: (i) anxiety increases the severity of autism in FXS, particularly through additional behavioral abnormalities; (ii) some neuropsychiatric and behavioral conditions (i.e., attention problems, hyperactivity/impulsivity, aggressiveness) are primarily related to comorbid anxiety, not autism; (iii) prevalence of behavioral abnormalities increases with age. Future studies evaluating these hypotheses should incorporate validated neurobehavioral assessments, and control for cognitive level.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  anxiety; autism; fragile X; survey

Mesh:

Substances:

Year:  2014        PMID: 24664669     DOI: 10.1002/ajmg.a.36468

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

1.  Prevalence and Predictors of Anxiety Disorders in Adolescent and Adult Males with Autism Spectrum Disorder and Fragile X Syndrome.

Authors:  Jordan Ezell; Abigail Hogan; Amanda Fairchild; Kimberly Hills; Jessica Klusek; Leonard Abbeduto; Jane Roberts
Journal:  J Autism Dev Disord       Date:  2019-03

2.  Extending the Parent-Delivered Early Start Denver Model to Young Children with Fragile X Syndrome.

Authors:  Laurie A Vismara; Carolyn E B McCormick; Rebecca Shields; David Hessl
Journal:  J Autism Dev Disord       Date:  2019-03

3.  Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.

Authors:  Walter E Kaufmann; Sharon A Kidd; Howard F Andrews; Dejan B Budimirovic; Amy Esler; Barbara Haas-Givler; Tracy Stackhouse; Catharine Riley; Georgina Peacock; Stephanie L Sherman; W Ted Brown; Elizabeth Berry-Kravis
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

4.  DSM-5 changes and the prevalence of parent-reported autism spectrum symptoms in Fragile X syndrome.

Authors:  Anne C Wheeler; Joanna Mussey; Adrienne Villagomez; Ellen Bishop; Melissa Raspa; Anne Edwards; James Bodfish; Carla Bann; Donald B Bailey
Journal:  J Autism Dev Disord       Date:  2015-03

5.  Characterising repetitive behaviours in young boys with fragile X syndrome.

Authors:  A Oakes; A J Thurman; A McDuffie; L M Bullard; R J Hagerman; L Abbeduto
Journal:  J Intellect Disabil Res       Date:  2015-10-08

6.  ASD Comorbidity in Fragile X Syndrome: Symptom Profile and Predictors of Symptom Severity in Adolescent and Young Adult Males.

Authors:  Leonard Abbeduto; Angela John Thurman; Andrea McDuffie; Jessica Klusek; Robyn Tempero Feigles; W Ted Brown; Danielle J Harvey; Tatyana Adayev; Giuseppe LaFauci; Carl Dobkins; Jane E Roberts
Journal:  J Autism Dev Disord       Date:  2019-03

7.  Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice.

Authors:  Patricia S Pirbhoy; Maham Rais; Jonathan W Lovelace; Walker Woodard; Khaleel A Razak; Devin K Binder; Iryna M Ethell
Journal:  J Neurochem       Date:  2020-06-08       Impact factor: 5.372

Review 8.  Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.

Authors:  Dejan B Budimirovic; Elizabeth Berry-Kravis; Craig A Erickson; Scott S Hall; David Hessl; Allan L Reiss; Margaret K King; Leonard Abbeduto; Walter E Kaufmann
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

9.  Parents' initial concerns about the development of their children later diagnosed with fragile X syndrome.

Authors:  Dajie Zhang; Walter E Kaufmann; Jeff Sigafoos; Katrin D Bartl-Pokorny; Magdalena Krieber; Peter B Marschik; Christa Einspieler
Journal:  J Intellect Dev Disabil       Date:  2016-09-18

Review 10.  Autism spectrum disorder in females with fragile X syndrome: a systematic review and meta-analysis of prevalence.

Authors:  M Marlborough; A Welham; C Jones; S Reckless; J Moss
Journal:  J Neurodev Disord       Date:  2021-07-23       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.